Malignant Neoplasm of Stomach Completed Phase 2 Trials for Floxuridine (DB00322)

Also known as: Gastric Cancers / Stomach Cancer / Gastric cancer / Gastric Malignancies / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified / Gastric malignancy

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00858338Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach CancerTreatment
NCT00002783Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach CancerTreatment
NCT00004103Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach CancerTreatment
NCT00005049Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal CancerTreatment
NCT00006038Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach CancerTreatment
NCT00183911Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric AdenocarcinomaTreatment